KMD Bioscience Co., Ltd.
400-621-6806
Service Line：+1-315-239-3085
Address：FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：info@kmdbioscience.com
| Catalog Number | YR1242 |
|---|---|
| Product Name | Anti-Human ITGA4 & ITGB7 Recombinant Antibody(Etrolizumab) |
| Molecular Name | Etrolizumab |
| Alias | Anti-ITGA4 & ITGB7 Recombinant Antibody, Research Grade Etrolizumab |
| CAS Number | 1044758-60-2 |
| Target | ITGA4 & ITGB7[Homo sapiens] |
| Isotype | IgG1 Kappa |
| Clonity | Monoclonal |
| Source | CHO Cells |
| Size | 1mg, 5mg |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Applications | IF, IP, Neut, FuncS, ELISA, FCM |
| Buffer | PBS, pH7.5 |
| Background | Etrolizumab (rhuMAb Beta7) is a biopharmaceutical drug candidate being developed for the treatment of ulcerative colitis and Crohn's disease. It is a humanized monoclonal antibody against the β7 subunit of integrins α4β7 and αEβ7. |
| Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Note | This product is for research use only. |
FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：info@kmdbioscience.com
Hot Line： +1-315-239-3085
Technical Support：sales@kmdbiosci.com
